Contrast-induced nephropathy remains a serious complication of PCI

J Interv Cardiol. 2007 Jun;20(3):236-40. doi: 10.1111/j.1540-8183.2007.00260.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Acetylcysteine / therapeutic use
  • Angioplasty, Balloon, Coronary / adverse effects*
  • Contrast Media / adverse effects*
  • Disease Progression
  • Fenoldopam / therapeutic use
  • Humans
  • Incidence
  • Kidney Diseases / chemically induced*
  • Kidney Diseases / prevention & control
  • Prognosis
  • Risk Factors
  • Sodium Bicarbonate / therapeutic use

Substances

  • Contrast Media
  • Sodium Bicarbonate
  • Fenoldopam
  • Acetylcysteine